Evidence map›Paper›PMID 40827183›Full record

ArticleCureus2025

Stereotactic Radiosurgery to the Nucleus Accumbens: A Dosimetric Feasibility Study.

Hayden F Byrd, Guozhen Luo, Betsy Crosswhite, Godwin Emeka-Ibe, Taylor Davis, Ryan Whitaker

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hayden F ByrdRadiation Oncology, Vanderbilt University Medical Center, Nashville, USA.
Guozhen LuoRadiation Oncology, Vanderbilt University Medical Center, Nashville, USA.
Betsy CrosswhiteRadiation Oncology, Vanderbilt University Medical Center, Nashville, USA.
Godwin Emeka-IbeRadiation Oncology, Vanderbilt University Medical Center, Nashville, USA.
Taylor DavisRadiology, Vanderbilt University Medical Center, Nashville, USA.
Ryan WhitakerRadiation Oncology, Vanderbilt University Medical Center, Nashville, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAddiction remains a critical issue in the United States, and options for individuals suffering from treatment-refractory addiction are limited. The nucleus accumbens (NAc) is a region of interest for both invasive and non-invasive interventions aimed at treating addiction. Stereotactic radiosurgery (SRS) is an established modality for managing benign conditions. This study seeks to establish the technical feasibility of targeting the NAc with linear accelerator-based SRS.

methodsA single de-identified image set from a patient previously treated with linac-based SRS for a benign condition was used. Computed tomography images of the patient's head, simulated in a stereotactic mask with corresponding high-resolution T1-weighted MRI brain and associated diffusion tensor imaging (DTI) data, were utilized for planning and localization. Three targets, named Ant, Mid, and Post, were placed on each side of the brain. Three separate plans were generated, targeting the bilateral NAc with one, two, and three shots to each side, with a maximal point dose of 140Gy, 120Gy, and 120Gy, respectively. The maximum dose to critical organs and volume of normal brain dose value V10Gy, V20Gy, and V60Gy were recorded.

resultsFor a two-shot plan, the maximum point dose to bilateral anterior targets was set to be 140Gy. The maximum dose to the optic chiasm, optical nerves, and brainstem was 5.4Gy, 3.6Gy, and 3.5Gy, respectively, with brain V20Gy of 1.0cc and V10Gy of 3.8cc. For a four-shot plan, bilateral Ant and Mid targets were targets with a maximum dose set to 120Gy. The resulting maximum dose to optic chiasm, optical nerves, and brainstem was 9.0Gy, 5.2Gy, and 5.4Gy, respectively, with brain V20Gy of 1.9cc and V10Gy of 8.4cc. Similar plans were created for a six-shot plan, with a maximum point dose of 120Gy. However, the maximum dose to the optical chiasm, optical nerve, and brainstem were 17.1Gy, 5.2Gy, and 5.4Gy, andthe brain V20Gy and V10Gy were 4.4cc and 22.3cc, respectively.

conclusionWe demonstrated the technical feasibility of targeting the NAc with SRS for the management of treatment-refractory addiction using a single sample patient. Two- and four-shot models appear to be most feasible to achieve the highest point-dose while respecting critical structure constraints. The attempt to add a six-shot drove the optical chiasm dose over our institutional constraint of 10 Gy in a single fraction due to the proximity to the chiasm. Demonstrating the efficacy and safety of radiosurgery to the NAc for addiction will require further carefully defined pre-clinical and clinical studies.

Indexed as

addiction therapydosimetry analysislinac-based srsopium addictionpsychiatric neurosurgeryradiation for benign disease

Identifiers

PMID40827183
PMCPMC12358088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.